Stock CHRS COHERUS BIOSCIENCES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Coherus BioSciences, Inc.

Equities

CHRS

US19249H1032

Market Closed - Nasdaq
Other stock markets
 01:30:00 01/06/2024 am IST 		5-day change 1st Jan Change
1.82 USD -3.19% Intraday chart for Coherus BioSciences, Inc. -4.71% -45.35%
23/05 Coherus Biosciences, Inc. Presents Preliminary Results from Phase I Dose Escalation Study of its Anti-Chemokine Receptor 8 Antibody, CHS-114, at the 2024 American Society of Clinical Oncology Annual Meeting CI
13/05 Truist Securities Trims Price Target on Coherus BioSciences to $7 From $8, Maintains Buy Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
COHERUS BIOSCIENCES, INC.
Bio Therapeutic Drugs
-3.19%-4.71%-45.35%-55.06%-90.37% 209M
Bearish
Bearish
Neutral

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. CHRS Stock
  4. Charts Coherus BioSciences, Inc.
  5. Comparison Chart